Cargando…
Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD
Overactivity of the noradrenergic (NE) system within the central nervous system (CNS) has been postulated as a key pathophysiology of posttraumatic stress disorder (PTSD). The activity of the enzyme salivary α-amylase (sAA) has been proposed as an indirect measure of CNS NE activity, and sAA is elev...
Autores principales: | McCall, William Vaughn, Pillai, Anilkumar, Pandya, Chirayu D., McCloud, Laryssa, Moraczewski, Jason A., Tauhidul, Liniya, Youssef, Nagy A., Case, Doug, Rosenquist, Peter B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517516/ https://www.ncbi.nlm.nih.gov/pubmed/31193114 http://dx.doi.org/10.1016/j.heliyon.2019.e01709 |
Ejemplares similares
-
Double-Blinded Randomized Pilot Clinical Trial Comparing Cognitive Side Effects of Standard Ultra-Brief Right Unilateral ECT to 0.5 A Low Amplitude Seizure Therapy (LAP-ST)
por: Youssef, Nagy A., et al.
Publicado: (2020) -
Twice Daily Prazosin and Valproic Acid in the Treatment of Flashbacks in PTSD
por: Fisher, Kristy A., et al.
Publicado: (2022) -
Magnitude of Reduction and Speed of Remission of Suicidality for Low Amplitude Seizure Therapy (LAP-ST) Compared to Standard Right Unilateral Electroconvulsive Therapy: A Pilot Double-Blinded Randomized Clinical Trial
por: Youssef, Nagy A., et al.
Publicado: (2019) -
Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents
por: Hudson, Nancy, et al.
Publicado: (2021) -
Case series: Continued remission of PTSD symptoms after discontinuation of prazosin
por: Richardson, Christie, et al.
Publicado: (2023)